| Product Name | MF | CAS | Details |
|---|
| Anti-FGFR1 / CD331 Reference Antibody (Lilly patent anti-FGFR-1) | Details |
| Anti-FGFR2 / CD332 Reference Antibody (aprutumab) | Details |
| Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab) | Details |
| Anti-FGFR3 / CD333 Reference Antibody (LY3076226) | Details |
| Anti-FGFR3 / CD333 Reference Antibody (vofatamab) | Details |
| Anti-FGFR4 / CD334 Reference Antibody (U3-1784) | Details |
| Anti-Fibronectin Reference Antibody (L19-TNF) | Details |
| Anti-Fibronectin Reference Antibody (radretumab) | Details |
| Anti-FLT3 / CD135 Reference Antibody (IMC-EB10) | Details |
| Anti-FOLH1 / PSMA Reference Antibody (pelgifatamAb) | Details |
| Anti-FOLH1 / PSMA Reference Antibody (rosopatamab) | Details |
| Anti-FOLR1 Reference Antibody (Dompe patent anti-FOLR1) | Details |
| Anti-FOLR1 Reference Antibody (farletuzumab) | Details |
| Anti-FOLR1 Reference Antibody (mirvetuximab) | Details |
| Anti-Fucosyl GM1 Reference Antibody (BMS-986012) | Details |
| Anti-FZD Reference Antibody (vantictumab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (zanidatamab) | Details |
| Anti-ERBB3 / HER3 Reference Antibody (barecetamab) | Details |
| Anti-ERBB3 / HER3 Reference Antibody (seribantumab) | Details |
| Anti-ERG Reference Antibody (Jackson Foundation patent anti-ERG) | Details |
| Anti-ETBR Reference Antibody (DEDN6526A) | Details |
| Anti-F11 / Factor XI Reference Antibody (abelacimab) | Details |
| Anti-F11 / Factor XI Reference Antibody (osocimab) | Details |
| Anti-F12 / Factor XII Reference Antibody (garadacimab) | Details |
| Anti-F8 / Factor VIII Reference Antibody (Novo Nordisk patent anti-Factor VIII) | Details |
| Anti-F9 / Factor IX Reference Antibody (emicizumab) | Details |
| Anti-FAP Reference Antibody (sibrotuzumab) | Details |
| Anti-FceR2 / CD23 Reference Antibody (lumiliximab) | Details |
| Anti-FcgR2a / CD32a Reference Antibody (VIB9600) | Details |
| Anti-FcgR3a / CD16a Reference Antibody (AFM13) | Details |
| Anti-FcRL5 / IRTA2 Reference Antibody (cevostamab) | Details |
| Anti-FcRL5 / IRTA2 Reference Antibody (DFRF4539A) | Details |
| Anti-FcRn (FCGRT & B2M) Reference Antibody (batoclimab) | Details |
| Anti-FcRn (FCGRT & B2M) Reference Antibody (nipocalimab) | Details |
| Anti-FcRn (FCGRT & B2M) Reference Antibody (orilanolimab) | Details |
| Anti-FcRn (FCGRT & B2M) Reference Antibody (rozanolixizumab) | Details |
| Anti-FGF19 Reference Antibody (1A6) | Details |
| Anti-FGF2 Reference Antibody (HuGAL-F2) | Details |
| Anti-FGF23 Reference Antibody (burosumab) | Details |
| Anti-ERBB3 / HER3 Reference Antibody (lumretuzumab) | Details |
| Anti-ERBB3 / HER3 Reference Antibody (patritumab) | Details |
| Anti-DCBLD2 / ESDN Reference Antibody (FA19-1) | Details |
| Anti-DC-SIGN / CD209 Reference Antibody (INSERM patent anti-DC-SIGN) | Details |
| Anti-DCSTAMP Reference Antibody (U.Rochester patent anti-DC-STAMP) | Details |
| Anti-DDR1 / CD167a Reference Antibody (Imperial College anti-DDR1) | Details |
| Anti-DKK1 Reference Antibody (BHQ-880) | Details |
| Anti-DLK1 Reference Antibody (LIV-1205) | Details |
| Anti-DLL3 Reference Antibody (Dragonfly patent anti-DLL3) | Details |
| Anti-DLL3 Reference Antibody (rovalpituzumab) | Details |
| Anti-DLL4 Reference Antibody (demcizumab) | Details |
| Anti-DLL4 Reference Antibody (enoticumab) | Details |
| Anti-DLL4 Reference Antibody (navicixizumab) | Details |
| Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4) | Details |
| Anti-DPEP3 Reference Antibody (tamrintamab) | Details |
| Anti-DPP4 / CD26 Reference Antibody (begelomab) | Details |
| Anti-DSG3 Reference Antibody (Forerunner patent anti-DSG3) | Details |
| Anti-Dysadherin Reference Antibody (Centrose patent anti-dysadherin) | Details |
| Anti-E8L Antibody (NL_A151) | Details |
| Anti-EFNA4 Reference Antibody (PF-06647263) | Details |
| Anti-EGFL7 Reference Antibody (parsatuzumab) | Details |
| Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147) | Details |
| Anti-Endoglin / CD105 Reference Antibody (carotuximab) | Details |
| Anti-ENTPD1 / CD39 Reference Antibody (TTX-030) | Details |
| Anti-EpCAM / TROP1 / CD326 Reference Antibody (adecatumumab) | Details |
| Anti-EpCAM / TROP1 / CD326 Reference Antibody (citatuzumab) | Details |
| Anti-EpCAM / TROP1 / CD326 Reference Antibody (oportuzumab) | Details |
| Anti-EphA2 Reference Antibody (MEDI-547) | Details |
| Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2) | Details |
| Anti-EphA3 Reference Antibody (ifabotuzumab) | Details |
| Anti-EphB2 Reference Antibody (Genentech patent anti-EphB2) | Details |
| Anti-EphB4 Reference Antibody (Morphosys patent anti-EphB4) | Details |
| Anti-EphB4 Reference Antibody (VasGene patent anti-EphB4) | Details |
| Anti-EPOR Reference Antibody (Abbott patent anti-EPO Receptor) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (7A7) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (cetuximab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Chinese Mil.Med.Sci. patent anti-EGFR) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (demupitamab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Duke D2C7) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (imgatuzumab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (laprituximAb) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (losatuxizumAb) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (matuzumab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (modotuximab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (necitumumab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (nimotuzumab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (pimurutamab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (tomuzotuximab) | Details |
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (zalutumumab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (gancotamab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (margetuximab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) | Details |
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (timigutuzumab) | Details |
| Product Total： Product Page： | ||||
| 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||